In contrast to leukemic mice NK cells, AML patients’ NK cells had similar levels of expression of CD98 and higher levels of expression of CD71 as compared to that of healthy donors (Supplemental Figure 6). This evidence concerns the gene TFRC and acute myeloid leukemia.